Skip to content

Author

Michael T. Lam

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Effect of IL-4RαR576 polymorphism on response to dupilumab in asthma, a genotype-stratified, randomized, placebo- controlled trial (IDEA Trial): Design, Rationale, Methods, Strategies, and Lessons Learned

Background: Asthma is a heterogeneous chronic disease, disproportionately affecting racial and ethnic minorities, with persistence and severity influenced by both environmental and genetic factors. The IL-4RαR576 variant occurs more commonly in racially minoritized, and the genotype, independent of race, is associated...

W. Phipatanakul, Elliot Israel, D. Mauger et al. · 0 citations
Review Sep 2026

Pumping the brakes: immune checkpoints as regulators of immunity and targets of cancer therapy.

An overview of the immunologic mechanisms and clinical features of irAEs is provided, discussing how the CTLA-4 and PD-1/PD-L1 immune checkpoints help maintain immune balance, and how their blockade results in unchecked immune activation.

Musaab Alhezam, Michael T. Lam, Seigo Okada et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.